Predicting pulmonary hemorrhage in very low birth weight infants

预测极低出生体重婴儿的肺出血

阅读:2

Abstract

BACKGROUND: Pulmonary hemorrhage (PH) in very low birth weight (VLBW) infants is a catastrophic event with significant mortality. Predicting PH clinically is challenging, with no tools for early detection. Our objective was to identify candidate physiologic biomarkers using heart rate (HR) and pulse oximetry (SpO(2)) predictive of PH events in VLBW infants. METHODS: We conducted a retrospective case-control study of VLBW infants from two level IV NICUs (2016-2023). We matched infants with PH to controls using gestational age, birth weight, and postnatal age. Taking HR and SpO(2) data from 72 hours before and after PH diagnosis and age-matched times for controls, we calculated a pulse oximetry warning score (POWS) using hourly mean, skewness, kurtosis, and cross-correlation of HR and SpO(2). RESULTS: We analyzed 48 infants, 24 PH cases, and 24 controls, with similar characteristics. Infants who developed PH exhibited a three-fold rise in POWS starting 24 hours before PH diagnosis. Control infants showed no significant change in POWS. CONCLUSION: POWS, a predictive model for cardiorespiratory deterioration, showed a rise in predicted risk before the clinical diagnosis of PH. This suggests that cardiorespiratory deterioration signatures precede the clinical diagnosis of PH and can be recognized with a computer algorithm. IMPACT: There are subtle vital sign changes that may indicate impending pulmonary hemorrhage in very low birth weight infants. Cardiorespiratory predictive monitoring could be useful for early warning of deterioration due to pulmonary hemorrhage. This study lays the foundation for the utility of predictive analytics for pulmonary hemorrhage prediction and suggests that a dedicated predictive model for pulmonary hemorrhage may be helpful.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。